Oskar Bosson
Vermögen: 246 326 $ am 31.05.2026
Vermögen: 246 326 $ am 31.05.2026
Mr. Oskar Bosson is a VP, Head-Investor Relations & Communications at BioArctic AB. Mr. Bosson was previously employed as an EVP-Corporate Communications & Public Affairs by Elekta AB, a Media Officer-Specialty Chemicals by Akzo Nobel NV, and a Head-Communications by Swedish Orphan Biovitrum AB. He received his undergraduate degree from the University of Uppsala and a graduate degree from the University of Uppsala.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
BIOARCTIC AB CLASS B 0.01% | 28.08.2025 | 6’454 ( 0.01% ) | 246 326 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| BIOARCTIC AB | Investor Relations Kontakt | 18.05.2020 |
| Unternehmen | Position | Ende |
|---|---|---|
| SWEDISH ORPHAN BIOVITRUM AB | Public Communications Contact | - |
| ELEKTA AB | Public Communications Contact | - |
| AKZO NOBEL N.V. | Public Communications Contact | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
Akzo Nobel NV
Akzo Nobel NV Industrial SpecialtiesProcess Industries Manufactures and sells decorative paints, performance coatings, and specialty chemicals | Process Industries |
Elekta AB
Elekta AB Medical SpecialtiesHealth Technology Manufactures radiation oncology and neurosurgery instruments | Health Technology |
University of Uppsala
University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioArctic AB
BioArctic AB Pharmaceuticals: MajorHealth Technology Develops drugs for patients with disorders of the central nervous systems | Health Technology |
Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals and orphan drugs in the areas of hematology, immunology and specialty care | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen